For the 15.5 million U.S. adults on GLP-1 medications like Ozempic and Wegovy, holiday meals can pose a challenge. Melanie ...

Lilly’s work discouraging cosmetic use of weight-loss drugs helped make it a 2024 Brands That Matter honoree. Use of GLP-1 ...

Now, research from Henry Ford Health, has found that weight-loss drugs, including GLP-1, could also impact alcohol ...

Struggles with obesity are a longstanding issue for millions of Americans and thousands of Iowans, but recent advancements in ...

The agency has yet to make a decision about keeping tirzepatide on or off of its shortage list — letting compound pharmacies ...

Elon Musk validated the use of GLP-1 drugs in a post on X on Wednesday. But Robert F. Kennedy Jr. has said he's opposed to Americans using them to fight obesity.

GLP-1 agonists substantially slowed kidney deterioration and failure, independent of diabetes status. The most extensive and ...

Zach Reitano, Ro CEO, joins 'Fast Money' to talk its latest GLP-1 offerings and how they are lowering price points for patients.

A bipartisan group of senators are filing a bill that would force health insurers or PBMs to divest their pharmacy businesses ...

Randomised controlled trials and real word evidence have consistently shown that GLP-1 receptor agonists are effective and acceptably safe for the treatment of type 2 diabetes and obesity, leading to ...

New findings presented at ASH indicated that GLP-1 agonists led to a significant reduction in the risk for dangerous blood ...

As new research suggests those taking GLP-1 drugs have fewer hospitalisations for alcoholism, a leading specialist warns ...